The New York-based investment firm FOS Capital Partners International has invested in CorporateHealth International ApS alongside the local fund Welfare Tech Invest.
Beginning of 2015 the German company CorporateHealth created a new business with headquarters in Odense, Denmark and started a pilot with Odense University Hospital and sundhed.dk.
They became part of the start-up development program run by Accelerace, established a unique public-private-partnership, and of course, created a unique product.
That recipe has now paid off for CorporateHealth.
The American investment firm FOS Capital Partners International and the local fund Welfare Tech Invest both have invested into CorporateHealth.
CorporateHealth provides an end-to-end, minimally invasive colorectal cancer screening service where citizens can be screened for cancer by swallowing a camera-pill conveniently at home instead of having a colonoscopy at the hospital.
Managing Director Cornelius Glismann points out that the openness in Denmark has been a key factor for CorporateHealth’s success.
– “In Denmark the system is more open minded towards innovative solutions – like our service around the camera pill – than I have experienced in Germany”
Next steps for CorporateHealth are scaling its service in Denmark and opening up new markets in other countries. In close collaboration with Sundhed.dk and OUH, CorporateHealth has already made contacts e.g. in Scotland. And with the new capital it becomes possible to pursue those opportunities decisively.